美国FDA药品数据库(U.S. FDA Drugs Database)
检索条件: 药品名称=CIPROFLOXACIN EXTENDED RELEASE
符合检索条件的记录共9
1 页 当前第 1 页  返回检索页
1药品名称CIPROFLOXACIN EXTENDED RELEASE
申请号077417产品号001
活性成分CIPROFLOXACIN; CIPROFLOXACIN HYDROCHLORIDE市场状态停止上市
剂型或给药途径TABLET, EXTENDED RELEASE;ORAL规格212.6MG;EQ 287.5MG BASE
治疗等效代码参比药物
批准日期2010/11/30申请机构ACTAVIS LABORATORIES FL INC
2药品名称CIPROFLOXACIN EXTENDED RELEASE
申请号077701产品号001
活性成分CIPROFLOXACIN; CIPROFLOXACIN HYDROCHLORIDE市场状态处方药
剂型或给药途径TABLET, EXTENDED RELEASE;ORAL规格425.2MG;EQ 574.9MG BASE
治疗等效代码AB参比药物
批准日期2007/03/26申请机构DR REDDYS LABORATORIES LTD
3药品名称CIPROFLOXACIN EXTENDED RELEASE
申请号077701产品号002
活性成分CIPROFLOXACIN; CIPROFLOXACIN HYDROCHLORIDE市场状态停止上市
剂型或给药途径TABLET, EXTENDED RELEASE;ORAL规格212.6MG;EQ 287.5MG BASE
治疗等效代码参比药物
批准日期2007/10/31申请机构DR REDDYS LABORATORIES LTD
4药品名称CIPROFLOXACIN EXTENDED RELEASE
申请号077809产品号001
活性成分CIPROFLOXACIN; CIPROFLOXACIN HYDROCHLORIDE市场状态停止上市
剂型或给药途径TABLET, EXTENDED RELEASE;ORAL规格425.2MG;EQ 574.9MG BASE
治疗等效代码参比药物
批准日期2010/11/30申请机构ACTAVIS LABORATORIES FL INC
5药品名称CIPROFLOXACIN EXTENDED RELEASE
申请号078166产品号001
活性成分CIPROFLOXACIN; CIPROFLOXACIN HYDROCHLORIDE市场状态处方药
剂型或给药途径TABLET, EXTENDED RELEASE;ORAL规格425.2MG;EQ 574.9MG BASE
治疗等效代码AB参比药物
批准日期2007/11/27申请机构ANCHEN PHARMACEUTICALS, INC
6药品名称CIPROFLOXACIN EXTENDED RELEASE
申请号078166产品号002
活性成分CIPROFLOXACIN; CIPROFLOXACIN HYDROCHLORIDE市场状态处方药
剂型或给药途径TABLET, EXTENDED RELEASE;ORAL规格212.6MG;EQ 287.5MG BASE
治疗等效代码AB参比药物
批准日期2007/11/27申请机构ANCHEN PHARMACEUTICALS, INC
7药品名称CIPROFLOXACIN EXTENDED RELEASE
申请号078183产品号001
活性成分CIPROFLOXACIN; CIPROFLOXACIN HYDROCHLORIDE市场状态处方药
剂型或给药途径TABLET, EXTENDED RELEASE;ORAL规格212.6MG;EQ 287.5MG BASE
治疗等效代码AB参比药物
批准日期2007/03/22申请机构MYLAN PHARMACEUTICALS INC
8药品名称CIPROFLOXACIN EXTENDED RELEASE
申请号078183产品号002
活性成分CIPROFLOXACIN; CIPROFLOXACIN HYDROCHLORIDE市场状态处方药
剂型或给药途径TABLET, EXTENDED RELEASE;ORAL规格425.2MG;EQ 574.9MG BASE
治疗等效代码AB参比药物
批准日期2007/03/22申请机构MYLAN PHARMACEUTICALS INC
9药品名称CIPROFLOXACIN EXTENDED RELEASE
申请号078712产品号001
活性成分CIPROFLOXACIN; CIPROFLOXACIN HYDROCHLORIDE市场状态停止上市
剂型或给药途径TABLET, EXTENDED RELEASE;ORAL规格212.6MG;EQ 287.5MG BASE
治疗等效代码参比药物
批准日期2007/12/11申请机构SANDOZ INC